BRINGING to market the first once per day single tablet, interferon-free hepatitis C therapy for Australian patients living with genotypes 1 or 4, MSD has announced the PBS funding of Zepatier (elbasvir and grazoprevir) effective 01 Jan 2017.
Coinciding with the PBS announcement is the launch of a new 'Spread the Cure' website for health professionals at spreadthecure.com.au, an innovative, interactive online portal designed to raise awareness of HCV and graphically track Australia's progress in the fight against HCV.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Dec 16
